Adar Poonawalla
Adar Poonawalla (born 14 January 1981) is the chief executive officer (CEO) of Serum Institute of India. Founded in 1966 by his father, Dr. Cyrus Poonawalla, it is the world's largest vaccine manufacturer by number of doses produced.
Adar Poonawalla was educated at the Bishops School (Pune), St. Edmund's School, Canterbury Kent (UK) followed by the University of Westminster (UK).
Adar Poonawalla joined Serum Institute in 2001 after graduating from the University of Westminster in London. Then exporting its products to 35 countries, Poonawalla concentrated on the company's international market and getting new products licensed and pre-qualified by the World Health Organization for supply to United Nations Agencies including UNICEF and PAHO. As of 2015, the company exports its products to over 140 countries; 85 percent of its revenues are from overseas.
In 2011, he became the CEO of Serum Institute of India with full control of day-to-day operations of the company. In 2012 he played a major role in the acquisition of Bilthoven Biologicals a Netherlands-based government vaccine manufacturing company. In 2017 he acquired Praha Vaccine Limited in the Czech Republic. Poonawalla is a board member of the GAVI Alliance, the global vaccine alliance.
He initiated and launched in 2014 Serum Institute's oral polio vaccine, which became a bestseller for the company. Every year he plans to launch a new vaccines for public health starting in 2017. In 2014, it was reported that he planned to expand the product portfolio to include vaccines for dengue, flu and cervical cancer
Reference
ليست هناك تعليقات:
إرسال تعليق